Product Name | MF | CAS | Details |
---|
ACJI-99C | C18H19N5O | 1135195-64-0 | Details |
Acetobixan | C16H17NO2S | 380201-24-1 | Details |
Aceratioside | C17H22O9 | 133084-09-0 | Details |
Ab42-IN-C2 | C15H16Cl2N2O2S2 | 439932-74-8 | Details |
ACEA1011 | C9H4ClF3N2O2 | 153504-72-4 | Details |
A-953227 | C25H20FN5O3 | 1037826-77-9 | Details |
A-933548 | C25H21N5O3 | 1037826-43-9 | Details |
A1B11 | C22H25N5O | 1602731-56-5 | Details |
A-424274 | C14H15N3 | 1335145-56-6 | Details |
5-Hydroxylansoprazole sulfone | C16H14F3N3O4S | 131927-00-9 | Details |
A-940894 | C17H21N5 | 1027330-82-0 | Details |
A457 | C26H33ClN2O3 | 1233923-95-9 | Details |
58-G3 | C14H12Cl2N4O5 | 287174-44-1 | Details |
A2B57 | C22H19N5O | 1602733-73-2 | Details |
Tecovirimat hydrate | C19H17F3N2O4 | 1162664-19-8 | Details |
20681-S | C21H29NO5S | 73361-71-4 | Details |
PF-06795071 | C18H17F4N3O3 | 2075629-81-9 | Details |
Semax acetate(80714-61-0 free base) | C37H51N9O10S.C2H4O2 | 2828433-33-4 | Details |
LBW242 | C27H42N4O2 | 867324-12-7 | Details |
Isoproterenol bitartrate | C11H17NO3.C4H6O6 | 59-60-9 | Details |
Fobrepodacin disodium | C21H27FN6NaO6P | 1384984-20-6 | Details |
Murizatoclax | C42H57ClN4O5S | 2245848-05-7 | Details |
(S)-Gyramide A | C21H27FN2O3S | 1000592-48-2 | Details |
Atopaxar hydrochloride | C29H39ClFN3O5 | 474544-83-7 | Details |
Ppc-1 | C21H25NO4 | 1245818-17-0 | Details |
Mebeverine alcohol D5 | C16H27NO2 | 2070015-15-3 | Details |
(+/-)-Terreic acid | C7H6O4 | 15255-24-0 | Details |
TT-232 TFA(147159-51-1 free base) | C45H58N10O9S2.C2HF3O2 | 2703745-48-4 | Details |
(R)-OR-S1 | C26H34BrN3O4 | 1809336-19-3 | Details |
13-Hydroxystevane | C20H34O | 5749-44-0 | Details |
AY 9944 dihydrochloride | C22H28Cl2N2 | 1245-84-7 | Details |
GLPG-3221 | C30H37F3N2O6 | 2222264-64-2 | Details |
UB 165 fumarate | C13H15ClN2.C4H4O4 | 2454492-43-2 | Details |
PPTN | C29H24F3NO2 | 1160271-30-6 | Details |
QPX7728 bis-acetoxy methyl ester | C15H14BFO8 | 2170834-56-5 | Details |
(S)-BI 665915 | C24H26N8O2 | 1360550-05-5 | Details |
Atiratecan | C31H34N6O6 | 867063-97-6 | Details |
VDR agonist 1 | C32H51N3O2 | 2269494-43-9 | Details |
Bocconoline | C22H21NO5 | 1322007-90-8 | Details |
Turbinaric acid | C27H44O2 | 56882-00-9 | Details |
7-Deoxyloganic acid | C16H24O9 | 22487-36-1 | Details |
AN11251 | C29H38BFO7 | 2130750-59-1 | Details |
BIZ 114 | C24H40O3 | 2099120-74-6 | Details |
RORγt Inverse agonist 2 | C27H25F8NO5S | 1801197-92-1 | Details |
Syk-IN-3 | C24H28N4O3S | 1312534-69-2 | Details |
Tyk2-IN-9 | C20H17N9 | 2127109-85-5 | Details |
SLLN-15 | C19H23N7Se2 | 2403650-93-9 | Details |
(Rac)-PF-06250112 | C22H20F2N6O2 | 1609465-88-4 | Details |
PKR activator 1 | C16H14N8OS2 | 2283420-62-0 | Details |
RORγt agonist 1 | C24H17F6NO5S | 2377378-89-5 | Details |
TP3011 | C26H26N4O5 | 534605-74-8 | Details |
BN201 | C25H38FN5O4 | 1361200-34-1 | Details |
(+)-SHIN1 | C24H24N4O2 | 2443966-90-1 | Details |
Alvameline maleate | C13H19N5O4 | 219581-36-9 | Details |
BMS-986163 | C23H28FN2O5P | 1801151-09-6 | Details |
PKR activator 2 | C18H16N8OS | 2283422-04-6 | Details |
Py-MPB-amino-C3-PBD | C41H44N8O6 | 2412924-07-1 | Details |
Isoxsuprine-monoester-1 | C23H31NO4 | 67160-74-1 | Details |
Methyl 3-[2-[[(4R)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]methylamino]ethyl]benzoate | C27H36N2O4 | 2725484-87-5 | Details |
TP-004 | C17H16F3N5O | 1454299-21-8 | Details |
RIP2 kinase inhibitor 1 | C17H17N5O2S | 2380028-10-2 | Details |
VBIT-3 | C21H19ClF3N3O3 | 2088463-66-3 | Details |
Oral antiplatelet agent 1 | C23H24N4O5S | 2299200-91-0 | Details |
Galidesivir triphosphate | C11H18N5O12P3 | 1467740-78-8 | Details |
ERRγ Inverse Agonist 1 | C30H37ClN2O2 | 2316832-86-5 | Details |
Lesopitron HCl | C15H21ClN6.ClH | 132449-88-8 | Details |
Levomecol | C16H18Cl2N4O7 | 118573-58-3 | Details |
Phortress free base | C20H23FN4OS | 741241-36-1 | Details |
DC4SMe | C35H31ClN5O7PS2 | 615538-47-1 | Details |
gamma-secretase modulator 1 hydrochloride | C24H25ClN4OS | 2741571-83-3 | Details |
DS08210767 | C31H39N5O2 | 2376334-75-5 | Details |
Glycosidase-IN-2 | C13H23NO5 | 476310-39-1 | Details |
OMDM-3 | C29H43NO3 | 616884-64-1 | Details |
OSMI-3 | C32H35N3O9S2 | 2260791-13-5 | Details |
Oxaquin | C31H33F2N4O11P | 790704-50-6 | Details |
PDE1-IN-3 | C18H24N4O | 2370966-46-2 | Details |
IDO1-IN-2 | C15H17FN6O4 | 2346614-58-0 | Details |
NR1H4 activator 1 | C34H53NO7S | 2242855-68-9 | Details |
PDE5-IN-2 | C25H21N3O6S | 2244517-61-9 | Details |
JBJ-02-112-05 | C27H20N4O2S | 2748162-29-8 | Details |
MCL-1/BCL-2-IN-4 | C26H23BrN2O5S | 2163793-56-2 | Details |
D-Cl-amidine | C14H19ClN4O2 | 1404060-15-6 | Details |
Dopamine D2 receptor antagonist-1 | C14H17N3S | 1055411-77-2 | Details |
Flibanserin-d4 | C20H21F3N4O | 2122830-90-2 | Details |
Integrin-IN-2 | C27H30N4O3 | 2378617-67-3 | Details |
OMDM-4 | C29H43NO3 | 616884-65-2 | Details |
Pulrodemstat Methylbenzenesulfonate | C31H31F2N5O5S | 2097523-57-2 | Details |
PDE9-IN-1 | C17H23FN6O2 | 2305087-92-5 | Details |
TLC3407-3786 | C19H19N3O4 | 896356-25-5 | Details |
PARP-2-IN-1 | C21H19F4N5O3 | 2115698-83-2 | Details |
Glucagon receptor antagonists-5 | C30H29ClF3N3O3 | 2200274-63-9 | Details |
Asteltoxin | C23H30O7 | 79663-49-3 | Details |
JAK-IN-4 | C18H22N4NaO6P | 1400877-37-3 | Details |
GPR40 agonist 1 | C27H30FN3O4 | 1853982-41-8 | Details |
HCV-IN-7 | C40H48N8O6S | 1449756-86-8 | Details |
JMV 2959 hydrochloride (925238-89-7 free base) | C30H32N6O2.ClH | 2448414-54-6 | Details |
GLP-1 receptor agonist 3 | C31H30FN5O4 | 2230200-09-4 | Details |
DC-5163 | C18H20ClN3OS | 897771-47-0 | Details |
Glycosidase-IN-1 | C13H23NO5 | 170376-12-2 | Details |
OSMI-2 | C26H25N3O7S2 | 2260542-60-5 | Details |
Product Total: Product Page: | ||||
138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 |